Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001493152-25-008084
Filing Date
2025-02-24
Accepted
2025-02-24 17:21:43
Documents
3
Period of Report
2025-02-24

Document Format Files

Seq Description Document Type Size
1 formpre14a.htm PRE 14A 667930
2 proxy_001.jpg GRAPHIC 377517
3 proxy_002.jpg GRAPHIC 235681
  Complete submission text file 0001493152-25-008084.txt   1513299
Mailing Address JFL CAPITAL MANAGEMENT 1017 RR 620 S, SUITE 107 LAKEWAY TX 78734
Business Address JFL CAPITAL MANAGEMENT 1017 RR 620 S, SUITE 107 LAKEWAY TX 78734 737 203 5270
Anebulo Pharmaceuticals, Inc. (Filer) CIK: 0001815974 (see all company filings)

EIN.: 851170950 | State of Incorp.: DE | Fiscal Year End: 0630
Type: PRE 14A | Act: 34 | File No.: 001-40388 | Film No.: 25658255
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)